Bonesupport Holding AB (publ) (FRA:2B4)

Germany · Delayed Price · Currency is EUR

17.82

+0.69 (4.03%)

At close: Jan 30, 2026

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Cerament Gentamicin and Ceramanent Vancomycin	652.80M
Cerament Gentamicin and Ceramanent Vancomycin Growth	82.23%
Cerament Bone Void Filler	226.89M
Cerament Bone Void Filler Growth	1.70%
Other	19.04M
Other Growth	95.38%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North America	715.94M
North America Growth	61.81%
United Kingdom	89.00M
United Kingdom Growth	21.25%
Europe and Rest of the World	82.98M
Europe and Rest of the World Growth	30.42%
Sweden	10.80M
Sweden Growth	-6.90%